Watchlist Price Alert

Zynerba Pharmaceuticals I... (ZYNE)

NASDAQ: ZYNE · Real-Time Price · USD

1.30

0.03 (2.36%)

At close: Oct 10, 2023, 10:00 PM

Zynerba Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	86K	86K	86K	86K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.25K	56.52K	255.93K	271.32K
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	86K	86K	86K	86K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.25K	56.52K	255.93K	271.32K
Operating Income	-38.79M	-36.82M	-35.25M	-35.4M	-37.12M	-37.79M	-36.77M	-38.12M	-37.14M	-49.15M	-52.06M	-53.29M	-45.98M	-35.65M	-34.32M	-30.95M	-37.01M	-37.47M	-40.4M	-40.56M	-41.12M	-37.52M	-32.82M	-31.3M	-28.75M	-26.67M	-23.21M	-21.94M	-19.94M	-15.28M
Interest Income	1.54M	1.2M	846.86K	444.02K	197.21K	111.46K	21.05K	21.54K	27.28K	47.94K	243.99K	534.21K	960.27K	1.37M	1.52M	1.55M	1.39M	1.14M	961.32K	795.91K	679.62K	617.85K	519.55K	390.33K	251.15K	144.73K	80.22K	53.24K	30.5K	12.38K
Pretax Income	-37.58M	-36.66M	-35.04M	-35.83M	-37.74M	-37.84M	-37.31M	-38.11M	-36.58M	-46.96M	-51.34M	-52.43M	-45.33M	-36.13M	-32.94M	-30.02M	-35.88M	-36.75M	-39.91M	-40.24M	-40.74M	-37.06M	-32.01M	-30.79M	-28.46M	-26.42M	-23.42M	-21.93M	-19.94M	-15.28M
Net Income	-37.01M	-36.77M	-35.5M	-36.7M	-38.43M	-37.84M	-37.31M	-38.11M	-36.58M	-46.96M	-51.34M	-52.43M	-45.33M	-36.13M	-32.94M	-30.02M	-35.88M	-36.75M	-39.91M	-40.24M	-40.74M	-37.06M	-32.01M	-30.79M	-28.46M	-26.37M	-23.39M	-21.93M	-19.94M	-15.34M
Selling & General & Admin	14.03M	13.79M	14.15M	14.75M	15.16M	15.83M	15.35M	16.1M	15.66M	15.77M	16.41M	15.79M	15.9M	14.69M	13.94M	13.23M	12.83M	12.98M	13.24M	12.36M	12.03M	11.23M	10.02M	9.42M	8.12M	6.96M	6.43M	6.81M	7.24M	6.39M
Research & Development	24.75M	23.03M	21.1M	20.65M	21.96M	21.96M	21.42M	22.02M	21.48M	33.38M	35.65M	37.5M	30.09M	20.96M	20.38M	17.8M	24.27M	24.58M	27.25M	28.2M	29.09M	26.29M	22.81M	21.88M	20.63M	19.71M	16.78M	15.19M	12.96M	9.16M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	38.79M	36.82M	35.25M	35.4M	37.12M	37.79M	36.77M	38.12M	37.14M	49.15M	52.06M	53.29M	45.98M	35.65M	34.32M	31.04M	37.1M	37.55M	40.48M	40.56M	41.12M	37.52M	32.82M	31.3M	28.75M	26.67M	23.21M	22M	20.19M	15.55M
Interest Expense	251.85K	343.55K	343.55K	343.55K	91.69K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	38.79M	36.82M	35.25M	35.4M	37.12M	37.79M	36.77M	38.12M	37.14M	49.15M	52.06M	53.29M	45.98M	35.65M	34.32M	31.04M	37.1M	37.55M	40.48M	40.56M	41.12M	37.52M	32.82M	31.3M	28.75M	26.67M	23.21M	22M	20.19M	15.55M
Income Tax Expense	-933.21K	111.17K	55.21K	370.95K	559.27K	-13.38K	476.74K	-71.59K	-626.44K	-2.25M	-785.49K	-890.74K	-687.32K	445.92K	-1.41M	-957.39K	-1.16M	-742.58K	-513.03K	-342.44K	-402.52K	-482.12K	-836.55K	-534.81K	-312.89K	-326.99K	145.97K	-16.48K	n/a	56.28K
Shares Outstanding (Basic)	50.15M	48.43M	45.13M	43.75M	41.41M	40.3M	40.23M	40.09M	40.07M	40.07M	29.32M	29.24M	26.1M	23.4M	23.19M	23.19M	22.12M	19.45M	17.62M	16.59M	13.5M	13.47M	13.42M	13.1M	13.05M	12.07M	9.68M	8.91M	8.86M	8.82M
Shares Outstanding (Diluted)	50.15M	48.43M	45.13M	43.75M	41.41M	40.3M	40.23M	40.09M	40.07M	40.07M	29.32M	29.24M	26.1M	23.4M	23.19M	23.19M	22.12M	19.45M	17.62M	16.59M	13.5M	13.47M	13.42M	13.1M	13.05M	12.07M	9.68M	8.91M	8.86M	8.82M
EPS (Basic)	-0.78	-0.82	-0.83	-0.88	-0.94	-0.94	-0.93	-1.04	-1.09	-1.62	-1.95	-2.08	-1.85	-1.57	-1.51	-1.49	-1.88	-2.27	-2.71	-2.87	-3.03	-2.78	-2.47	-2.58	-2.62	-2.68	-2.57	-2.45	-2.44	-1.93
EPS (Diluted)	-0.78	-0.82	-0.83	-0.88	-0.94	-0.94	-0.93	-1.04	-1.09	-1.62	-1.95	-2.08	-1.85	-1.57	-1.51	-1.49	-1.88	-2.27	-2.71	-2.87	-3.03	-2.78	-2.47	-2.58	-2.62	-2.68	-2.57	-2.45	-2.44	-1.93
EBITDA	-38.47M	-36.5M	-34.93M	-34.93M	-37.14M	-37.81M	-36.79M	-38.27M	-37.29M	-49.3M	-52.21M	-53.39M	-46.08M	-35.75M	-34.42M	-31.02M	-37.08M	-37.54M	-40.47M	-40.62M	-41.19M	-37.58M	-32.89M	-31.36M	-28.8M	-26.72M	-23.26M	-21.93M	-19.92M	-15.26M
EBIT	-16.84M	-26.6M	-26.6M	-18.19M	-9.76M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	430.96K	1.2M	1.11M	1.44M	1.01M	246.38K	247.14K	245.03K	240.92K	227.27K	207.03K	182.93K	161.16K	145.84K	133.88K	124.58K	113.6K	102.26K	99.57K	99.04K	98.77K	100.36K	94.21K	90.38K	91.45K	82.16K	75.3K	66.55K	48.94K	38.14K